On October 27, 2026, 汇添富基金管理股份有限公司 sold 991,000 shares of KEYMED BIO-B (02162) on the SEHK open market at an average price of HKD 70.8951 per share, involving about HKD 70.26 million; this was an on-exchange trade.
Prior to the disposal, 汇添富基金管理股份有限公司’s long position in KEYMED BIO-B was 15.19 million shares, representing 5.08%; following the disposal, the holding changed to 14.20 million shares, with the long position ratio falling to 4.75%.
Source: Hong Kong Exchanges and Clearing Limited.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments